Cargando…
GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation
BACKGROUND: The role of GLIS2 in fibrotic diseases is controversial. GLIS2 deficiency has been reported to contribute to renal fibrosis in mice and has also been reported to prevent high lipid-induced mice hepatic fibrosis. METHODS: Hepatic fibrosis in mice was induced by CCl4. Hematoxylin and eosin...
Autores principales: | Zhang, Haoye, Zhou, Pengcheng, Xing, Wu, Chen, Limin, Zhou, Yangmei, Yang, Hui, Fu, Kangkang, Liu, Zhenguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792572/ https://www.ncbi.nlm.nih.gov/pubmed/36397300 http://dx.doi.org/10.1016/j.jcmgh.2022.10.015 |
Ejemplares similares
-
Transcriptional regulation of Glis2 in hepatic fibrosis
por: Gong, Huan-Yu, et al.
Publicado: (2023) -
Author Correction: Transcriptional regulation of Glis2 in hepatic fibrosis
por: Gong, Huan-Yu, et al.
Publicado: (2023) -
Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
por: Li, Wenhao, et al.
Publicado: (2020) -
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
por: Liu, Ya-Wei, et al.
Publicado: (2015) -
A circular RNA derived from GLIS3 accelerates the proliferation of glioblastoma cells through competitively binding with miR-449c-5p to upregulate CAPG and GLIS3
por: Zhou, Qingjiu, et al.
Publicado: (2022)